Revision 1
Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Kit Includes* Quantity Applications Dilution Isotype
Phospho-p38 MAPK (Thr180/Tyr182) (D3F9) XP™ Rabbit mAb 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Phospho-MAPKAPK-2 (Thr334) (27B7) Rabbit mAb 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Phospho-HSP27 (Ser82) Antibody II 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Phospho-SAPK/JNK (Thr183/Tyr185) (G9) Mouse mAb 140 µl HCA, ICW, IF-IC 1:10 Mouse IgG1
Phospho-c-Jun (Ser73) (D47G9) XP™ Rabbit mAb 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Phospho-p53 (Ser15) (16G8) Mouse mAb 140 µl HCA, ICW, IF-IC 1:10 Mouse IgG1
Cleaved Caspase-3 (Asp175) Antibody 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Cleaved PARP (Asp214) Antibody (Human Specific) 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG

*Component formulation specific to kit.

Applications Key: HCA=High Content Analysis, ICW=In-Cell Western, IF-IC=Immunofluorescence (Immunocytochemistry)

Description

CST’s PathScan® Multi-Target HCA Stress and Apoptosis Kit contains eight primary antibodies that target cellular stress and apoptotic signaling pathways. This kit is designed to elucidate the signaling occurring through key pathway nodes using automated imaging or laser scanning platforms or manual immunofluorescent microscopy. The kit provides the investigator with a quick and easy means to choose the endpoints that will be the most robust and useful for subsequent studies, whether large high content/high throughput screening projects or single small-scale experiments. The antibodies are supplied at 10X of their optimal dilution for immunofluorescent applications. This allows the antibodies to be easily diluted to their 1X working concentrations and dispensed into multi-well plates or slides. 140 μl of each antibody is supplied, which is sufficient for 24 wells on 96-well plates (50 μl 1X per well) or one row on two 96-well plates.

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

Background

Cellular stress and apoptosis involve a complex network of signaling pathways that maintain cellular homeostasis when confronted with a variety of potentially damaging effectors, including UV and gamma radiation, chemotherapeutic agents, osmotic shock, inflammatory cytokines, and other environmental stresses. The manner in which cells respond to stress has become an important metric in the study of disease due to the potential deregulation of these pathways in disease states. For example, cancer cells can affect these pathways to promote cell growth and metastasis (1). Some of the key members involved in stress-activated signaling belong to the mitogen-activated protein kinase (MAPK) pathway. The stress-activated protein kinase/Jun-amino-terminal kinase (SAPK/JNK) is one such member that is potently and preferentially activated by a variety of environmental stresses (2-7). SAPK/JNK, when active as a dimer, can translocate to the nucleus where it regulates transcription through its effects on transcription factors such as c-Jun (4,6). Activation of c-Jun by phosphorylation at Ser63 and Ser73 through SAPK/JNK affects a diverse array of biological functions including cell proliferation, differentiation, and apoptosis (8). Similar to the SAPK/JNK pathway, p38 MAPK is activated by a variety of cellular stresses (9-13). When phosphorylated at Thr180 and Tyr182, p38 MAPK has been shown to activate MAP kinase-activated protein kinase 2 (MAPKAPK-2) and the transcription factors ATF-2, Max, and MEF2 (11-16). Phosphorylation at Thr222, Ser272, and Thr334 appears to be essential for the activity of MAPKAPK-2 (17), which can result in the phosphorylation of heat shock protein (HSP) 27 at Ser15, Ser78, and Ser82 (9,18). HSP27 is one of the small HSPs that are constitutively expressed at different levels in various cell types and tissues. In response to stress, the expression level of HSP27 increases several-fold to confer cellular resistance to the adverse environmental change (18). The SAPK/JNK and p38 MAPK pathways also contribute to cell cycle checkpoint control through the activation of the p53 tumor suppressor protein, which plays a major role in cellular response to DNA damage and other genomic aberrations (19). Activation of p53 can lead to either cell cycle arrest and DNA repair or apoptosis (20). Stress-activated pathways also control the transcription of apoptotic proteins and mediators, thereby playing an important role in apoptosis and cell survival. Apoptosis is a regulated cellular suicide mechanism characterized by nuclear condensation, cell shrinkage, membrane blebbing, and DNA fragmentation (21). Cell survival requires the active suppression of apoptosis, which is accomplished by inhibiting the expression of pro-apoptotic factors as well as promoting the expression of anti-apoptotic factors. Caspases, a family of cysteine proteases, are the central regulators of apoptosis. Initiator caspases (including caspase-2, -8, -9, -10, -11, and -12) are closely coupled to pro-apoptotic signals. Once activated, these caspases cleave and activate downstream effector caspases (including caspase-3, -6, and -7), which in turn execute apoptosis by cleaving cellular proteins following specific asparagine residues (1). Caspase-3 is a critical executioner of apoptosis, as it is either partially or totally responsible for the proteolytic cleavage of many key proteins such as the nuclear enzyme poly (ADP-ribose) polymerase (PARP) (22). PARP appears to be involved in DNA repair in response to environmental stress (23). PARP helps cells to maintain their viability; cleavage of PARP facilitates cellular disassembly and serves as a marker of cells undergoing apoptosis (24).

  1. Herr, I. and Debatin, K.M. (2001) Blood 98, 2603-14.
  2. Davis, R.J. (1999) Biochem Soc Symp 64, 1-12.
  3. Ichijo, H. (1999) Oncogene 18, 6087-93.
  4. Kyriakis, J.M. and Avruch, J. (2001) Physiol Rev 81, 807-69.
  5. Kyriakis, J.M. (1999) J Biol Chem 274, 5259-62.
  6. Leppä, S. and Bohmann, D. (1999) Oncogene 18, 6158-62.
  7. Whitmarsh, A.J. and Davis, R.J. (1998) Trends Biochem Sci 23, 481-5.
  8. Davis, R.J. (2000) Cell 103, 239-52.
  9. Rouse, J. et al. (1994) Cell 78, 1027-37.
  10. Han, J. et al. (1994) Science 265, 808-11.
  11. Lee, J.C. et al. Nature 372, 739-46.
  12. Freshney, N.W. et al. (1994) Cell 78, 1039-49.
  13. Raingeaud, J. et al. (1995) J Biol Chem 270, 7420-6.
  14. Zervos, A.S. et al. (1995) Proc Natl Acad Sci U S A 92, 10531-4.
  15. Zhao, M. et al. (1999) Mol Cell Biol 19, 21-30.
  16. Yang, S.H. et al. (1999) Mol Cell Biol 19, 4028-38.
  17. Ben-Levy, R. et al. (1995) EMBO J 14, 5920-30.
  18. Landry, J. et al. (1992) J Biol Chem 267, 794-803.
  19. Reinhardt, H.C. and Yaffe, M.B. (2009) Curr Opin Cell Biol 21, 245-55.
  20. Levine, A.J. (1997) Cell 88, 323-31.
  21. Elmore, S. (2007) Toxicol Pathol 35, 495-516.
  22. Fernandes-Alnemri, T. et al. (1994) J Biol Chem 269, 30761-4.
  23. Satoh, M.S. and Lindahl, T. (1992) Nature 356, 356-8.
  24. Oliver, F.J. et al. (1998) J Biol Chem 273, 33533-9.

Background References

    Trademarks and Patents

    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    PathScan is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

    使用に関する制限

    法的な権限を与えられたCSTの担当者が署名した書面によって別途明示的に合意された場合を除き、 CST、その関連会社または代理店が提供する製品には以下の条件が適用されます。お客様が定める条件でここに定められた条件に含まれるものを超えるもの、 または、ここに定められた条件と異なるものは、法的な権限を与えられたCSTの担当者が別途書面にて受諾した場合を除き、拒絶され、 いかなる効力も効果も有しません。

    研究専用 (For Research Use Only) またはこれに類似する表示がされた製品は、 いかなる目的についても FDA または外国もしくは国内のその他の規制機関により承認、認可または許可を受けていません。 お客様は製品を診断もしくは治療目的で使用してはならず、また、製品に表示された内容に違反する方法で使用してはなりません。 CST が販売または使用許諾する製品は、エンドユーザーであるお客様に対し、使途を研究および開発のみに限定して提供されるものです。 診断、予防もしくは治療目的で製品を使用することまたは製品を再販売 (単独であるか他の製品等の一部であるかを問いません) もしくはその他の商業的利用の目的で購入することについては、CST から別途許諾を得る必要があります。 お客様は以下の事項を遵守しなければなりません。(a) CST の製品 (単独であるか他の資材と一緒であるかを問いません) を販売、使用許諾、貸与、寄付もしくはその他の態様で第三者に譲渡したり使用させたりしてはなりません。また、商用の製品を製造するために CST の製品を使用してはなりません。(b) 複製、改変、リバースエンジニアリング、逆コンパイル、 分解または他の方法により製品の構造または技術を解明しようとしてはなりません。また、 CST の製品またはサービスと競合する製品またはサービスを開発する目的で CST の製品を使用してはなりません。(c) CST の製品の商標、商号、ロゴ、特許または著作権に関する通知または表示を除去したり改変したりしてはなりません。(d) CST の製品をCST 製品販売条件(CST’s Product Terms of Sale) および該当する書面のみに従って使用しなければなりません。(e) CST の製品に関連してお客様が使用する第三者の製品またはサービスに関する使用許諾条件、 サービス提供条件またはこれに類する合意事項を遵守しなければなりません。